CLCFF (Christina Lake Cannabis) Net-Net Working Capital: $-0.01 (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Christina Lake Cannabis Net-Net Working Capital?

Christina Lake Cannabis CLCFF -8.93% Net-Net Working Capital is $-0.01 as of Nov. 2025. The stock has 5 warning signs investors should review. Among 415 Drug Manufacturers companies, Christina Lake Cannabis ranks worse than 240963.61% on this metric.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Christina Lake Cannabis's Net-Net Working Capital for the quarter that ended in Nov. 2025 was $-0.01.

The industry rank for Christina Lake Cannabis's Net-Net Working Capital or its related term are showing as below:

CLCFF's Price-to-Net-Net-Working-Capital is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.77
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Christina Lake Cannabis  (OTCPK:CLCFF) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Christina Lake Cannabis Net-Net Working Capital Related Terms


Christina Lake Cannabis Net-Net Working Capital Historical Data

* Premium members only.

The historical data trend for Christina Lake Cannabis's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Christina Lake Cannabis Net-Net Working Capital Chart

Christina Lake Cannabis Annual Data
Trend Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Net-Net Working Capital
Get a 7-Day Free Trial 0.00 -0.03 -0.03 -0.01 -0.02

Christina Lake Cannabis Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 May25 Aug25 Nov25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.02 -0.01 -0.01 -0.01

CLCFF vs ZTS, UTHR: Net-Net Working Capital Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Christina Lake Cannabis's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Christina Lake Cannabis Price-to-Net-Net-Working-Capital vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Christina Lake Cannabis's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Christina Lake Cannabis's Price-to-Net-Net-Working-Capital falls into.



Christina Lake Cannabis Net-Net Working Capital Calculation

Christina Lake Cannabis's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Nov. 2023 is calculated as

Net-Net Working Capital(A: Nov. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.071+0.75 * 1.347+0.5 * 4.126-6.202
-0-0)/131.122
=-0.02

Christina Lake Cannabis's Net-Net Working Capital (NNWC) per share for the quarter that ended in Nov. 2025 is calculated as

Net-Net Working Capital(Q: Nov. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.187+0.75 * 0.827+0.5 * 9.649-7.951
-0-0)/248.094
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.

What does a Net-Net Working Capital of $-0.01 mean?
Christina Lake Cannabis (CLCFF) has a Net-Net Working Capital of $-0.01 as of Nov. 2025. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Christina Lake Cannabis According to the industry distribution chart, Christina Lake Cannabis ranks #999999 out of 415 companies in the Drug Manufacturers industry.
Is Christina Lake Cannabis' Net-Net Working Capital too high?
Christina Lake Cannabis' current Net-Net Working Capital is $-0.01. Based on the distribution chart, Christina Lake Cannabis ranks #999999 out of 415 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Christina Lake Cannabis' Net-Net Working Capital compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Christina Lake Cannabis ranks #999999 out of 415 companies for Net-Net Working Capital. This places Christina Lake Cannabis in the lower half of its industry. The industry median Net-Net Working Capital is 7.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Drug Manufacturers company?
The median Net-Net Working Capital among Drug Manufacturers companies is 7.77, based on 415 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Christina Lake Cannabis For the Drug Manufacturers industry, the median Net-Net Working Capital is 7.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Christina Lake Cannabis's current Net-Net Working Capital is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Christina Lake Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Christina Lake Cannabis (CLCFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.04, compared to a current price of $0.02 — trading 51.8% below its estimated fair value. The current Net-Net Working Capital is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For Christina Lake Cannabis (CLCFF), the current Net-Net Working Capital is $-0.01 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Christina Lake Cannabis Business Description

Other Exchanges CLB:GermanyCLC:Canada
Address 1075 West Georgia Street, Suite 1890, Vancouver, BC, CAN, V6E 3C9
Christina Lake Cannabis Corp is a licensed producer of cannabis. The company cultivates cannabis using strains specifically developed for outdoor cultivation. It is a producer of high-quality, low-cost, sun-grown cannabis flowers, oil cannabinoids, and hemp-based extracts and derivatives, serving domestic and international markets.